Dignitana AB (publ) operates as a medical technology enterprise, concentrating on the creation, production, and global distribution of specialized medical cooling devices, with significant activity in the United States. Its flagship product is DigniCap, a scalp cooling system specifically engineered to mitigate hair loss that can arise from particular chemotherapy protocols, notably those employed in breast cancer treatment. The company was established in 2007 and is headquartered in Lund, Sweden.